Skip to main content

ADVERTISEMENT

Interventional oncology

News
12/03/2014
Challenges the Status Quo in Minimally Invasive Procedures with Improved Workflow, Accuracy and SafetyNovember 30, 2014 06:00 AM Eastern Standard TimeRSNA 2014CHICAGO--(BUSINESS WIRE)--As the first seamless integration between Interventional...
Challenges the Status Quo in Minimally Invasive Procedures with Improved Workflow, Accuracy and SafetyNovember 30, 2014 06:00 AM Eastern Standard TimeRSNA 2014CHICAGO--(BUSINESS WIRE)--As the first seamless integration between Interventional...
Challenges the Status Quo in...
12/03/2014
IO Learning
Interview
11/24/2014
As 2014 winds down, the impact of interventional oncology continues to be felt around the globe. Three meetings with a focus on IO concluded in Malaysia, Argentina, and Shanghai between October and November of 2014.The Malaysian Society of...
As 2014 winds down, the impact of interventional oncology continues to be felt around the globe. Three meetings with a focus on IO concluded in Malaysia, Argentina, and Shanghai between October and November of 2014.The Malaysian Society of...
As 2014 winds down, the impact...
11/24/2014
IO Learning
News
11/18/2014
Leuven, Belgium, November 4, 2014 - Terumo Europe today announced the creation of an Interventional Oncology division as of April 1st, 2015.Interventional cardiology and oncology as well as treatment of peripheral artery disease (PAD) are the...
Leuven, Belgium, November 4, 2014 - Terumo Europe today announced the creation of an Interventional Oncology division as of April 1st, 2015.Interventional cardiology and oncology as well as treatment of peripheral artery disease (PAD) are the...
Leuven, Belgium, November 4,...
11/18/2014
IO Learning
News
09/02/2014
London, UK, 28 August 2014: BTG plc (LSE: BTG), the specialist healthcare company, and its partner SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN), a China-focused specialty pharmaceutical company, today announce that the China Food and Drug...
London, UK, 28 August 2014: BTG plc (LSE: BTG), the specialist healthcare company, and its partner SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN), a China-focused specialty pharmaceutical company, today announce that the China Food and Drug...
London, UK, 28 August 2014: BTG...
09/02/2014
IO Learning
News
08/07/2014
Superb Microvascular Imaging Helps Clinicians Deliver a More Accurate DiagnosisAugust 07, 2014 03:00 AM Eastern Daylight Time, Society of Vascular Ultrasound (SVU) Annual Conference -- LAKE BUENA VISTA, Fla.--(BUSINESS WIRE)--Toshiba is...
Superb Microvascular Imaging Helps Clinicians Deliver a More Accurate DiagnosisAugust 07, 2014 03:00 AM Eastern Daylight Time, Society of Vascular Ultrasound (SVU) Annual Conference -- LAKE BUENA VISTA, Fla.--(BUSINESS WIRE)--Toshiba is...
Superb Microvascular Imaging...
08/07/2014
IO Learning
Clinical Insights
07/09/2014

Mary P. Orencole, MS, ANP-BC; Carly Crocker, BS; Sanjeev Francis, MD
Resynchronization and Advanced Cardiac Therapeutics and Cardio-Oncology programs at Massachusetts General Hospital Boston, Massachusetts

Mary P. Orencole, MS, ANP-BC; Carly C...
According to the National Cancer Institute, approximately 14 million Americans with a history of cancer were alive in 2012. Survival from cancer has improved significantly over the last several decades due in large part to advances in...
According to the National Cancer Institute, approximately 14 million Americans with a history of cancer were alive in 2012. Survival from cancer has improved significantly over the last several decades due in large part to advances in...
According to the National Cancer...
07/09/2014
IO Learning
News
06/27/2014
June 26, 2014 11:12 AM Eastern Daylight Time--MAYNARD, Mass.--(BUSINESS WIRE)--Ischemix, Inc., a pharmaceutical company developing a portfolio of cytoprotective compounds to address serious diseases, is pleased to announce that it has...
June 26, 2014 11:12 AM Eastern Daylight Time--MAYNARD, Mass.--(BUSINESS WIRE)--Ischemix, Inc., a pharmaceutical company developing a portfolio of cytoprotective compounds to address serious diseases, is pleased to announce that it has...
June 26, 2014 11:12 AM Eastern...
06/27/2014
IO Learning
News
06/20/2014
June 19, 2014 16:05 | Source: Vascular Solutions, Inc.- Precisely sized, bioresorbable gelatin beads intended for embolization of hypervascular tumors- Designed for use by interventional radiologists who currently use microspheres, PVA...
June 19, 2014 16:05 | Source: Vascular Solutions, Inc.- Precisely sized, bioresorbable gelatin beads intended for embolization of hypervascular tumors- Designed for use by interventional radiologists who currently use microspheres, PVA...
June 19, 2014 16:05 | Source:...
06/20/2014
IO Learning
Interview
06/17/2014
SIR 2014, the society’s 39th annual scientific meeting, was held in San Diego between March 23 and 27. The theme this year was “Convergence,” keeping in line with the multidimensional nature of IR in daily practice. Plenary sessions, abstract...
SIR 2014, the society’s 39th annual scientific meeting, was held in San Diego between March 23 and 27. The theme this year was “Convergence,” keeping in line with the multidimensional nature of IR in daily practice. Plenary sessions, abstract...
SIR 2014, the society’s 39th...
06/17/2014
IO Learning
News
06/05/2014
June 05, 2014 01:45 AM Eastern Daylight TimeLONDON--(BUSINESS WIRE)--Regulatory News:“The development of MRI-guided radiation therapy establishes a new vision for clinical radiation oncology for the treatment of cancer”Elekta (NSE:EKTAb) and...
June 05, 2014 01:45 AM Eastern Daylight TimeLONDON--(BUSINESS WIRE)--Regulatory News:“The development of MRI-guided radiation therapy establishes a new vision for clinical radiation oncology for the treatment of cancer”Elekta (NSE:EKTAb) and...
June 05, 2014 01:45 AM Eastern...
06/05/2014
IO Learning